Open AccessA randomized, Double-Blind, Placebo-Controlled Multicenter Study of Kan Jang® Capsules in Patients with URTI Infection with the Primary Outcome of Sick Leave Days
Author(s) -
G. Wikman
Publication year - 2021
Publication title -
hsoa journal of alternative, complementary and integrative medicine
Language(s) - English
Resource type - Journals
ISSN - 2470-7562
DOI - 10.24966/acim-7562/100161
Subject(s) - placebo , sick leave , medicine , double blind , double blind study , physical therapy , alternative medicine , pathology
In this study, we also found that the sick leave for the placebo group was 1.79 days, while the sick leave in the Kan Jang group was reduced to 0.44 days.